- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05378958
Qualitative Phenomenological Study on Videoconferencing Therapeutic Education (Visio ETP)
Qualitative Phenomenological Study on Remote Therapeutic Education by Videoconferencing Crossing the Participant and Caregiver View
Therapeutic patient education (TPE) is one of the mechanisms that make patients with chronic disease as competent as possible to manage illness and treatment by helping them to be autonomous and responsible for their decision-making.
The COVID-19 pandemic has changed the organization of care, prioritizing the emergency fight against the epidemic.
The French High Authority of Health (HAS) has recommended maintaining individual TPE sessions by videoconference or telephone, based on the usual stages of the educational process. Several working groups have looked into remote TPE and recommendations have been issued in the form of practical advice but without questioning the participants, who did not participate in the reflection. No consensus, including health authorities, has been reached on this subject.
At Necker Hospital, ETPs were carried out remotely, by videoconference. Understanding remote therapeutic education by videoconference through lived experience, by means of a one-hour interview, of the caregivers who deliver it and the parents of patients or the patients who receive it, will make it possible to better understand the effects of remote mode on therapeutic education sessions but also on professional practices and on participants.
The benefit will be twofold: for caregivers: to facilitate the deployment of this new educational offer. For patients and their carers: give priority access to TPE to families who are far from the healthcare system or to patients who are too fragile to travel and thus reduce inequalities and geographical barriers.
Study Overview
Detailed Description
Chronic disease onset, due to its lasting and progressive nature, generates significant personal, family and socio-professional disabilities and difficulties. This situation requires active participation on the part of the patient, who must adopt protective behaviors in order to live better as much as possible.
Therapeutic patient education (TPE) is one of the mechanisms that will make patients as competent as possible to manage illness and treatment by helping them to be autonomous and responsible for their decision-making.
The COVID-19 pandemic has changed the organization of care, prioritizing the emergency fight against the epidemic. The TPE programs were also impacted by the pandemic.The French High Authority of Health (HAS) has recommended maintaining individual TPE sessions by videoconference or telephone, based on the usual stages of the educational process, without however defining clear recommendations for remote TPE. Several working groups have looked into remote TPE and recommendations have been issued in the form of practical advice without questioning the participants, who did not participate in the reflection. No consensus, including health authorities, has been reached on this subject.
At Necker Hospital, ETPs were carried out remotely, by videoconference. This new way of providing training required upstream preparation, reflection on the content, the use of digital tools and their mastery on the part of participants and speakers. The purpose of this qualitative study is to understand remote therapeutic education by videoconference through lived experience, by means of a one-hour interview, of the caregivers who deliver it and the parents of patients or the patients who receive it. The interviews will make it possible to better understand the effects of distant mode on therapeutic education sessions on participants but also on professional's practices. The benefit will be twofold: for caregivers: to facilitate the deployment of this new educational offer. For patients and their carers: give priority access to TPE to families who are far from the healthcare system or to patients who are too fragile to travel and thus reduce inequalities and geographical barriers.
Study Type
Contacts and Locations
Study Contact
- Name: Cécile Godot, MD
- Phone Number: +33 1 44 49 51 16
- Email: cecile.godot@aphp.fr
Study Contact Backup
- Name: Hélène Morel
- Phone Number: 1 71 19 63 46
- Email: helene.morel@aphp.fr
Study Locations
-
-
-
Paris, France, 75015
- Hopital Necker-Enfants Malades
-
Contact:
- Cécile Godot, MD
- Phone Number: +33 1 44 49 51 16
- Email: cecile.godot@aphp.fr
-
Sub-Investigator:
- Radhia Dahmane
-
Sub-Investigator:
- Théo Teng
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Understanding of the French language (oral and written) for all participants.
- Information and non-opposition of the subjects and of holders of parental authority of minor subjects.
- Caregivers: any health professional practicing videoconferencing therapeutic education can be included without age limit, regardless of gender, profession exercised (medical or paramedical) or the program concerned as long as the program is authorized (or declared) to authorized by the Ile-de-France Regional Health Agency (ARS).
Participants: depending on the age of the patients, parents can be the exclusive target of therapeutic education (especially for young patients) or be present with their child during the sessions. The participants are the beneficiaries of therapeutic education either:
- Parents/caregivers who have taken part in a videoconferencing TPE session (individual or collective) as part of a program authorized by the Ile-de-France ARS, regardless of their age, sex or the pathology concerned in the education program.
- Patients: from 10 years old and only if the videoconferencing therapeutic education session was intended for them, regardless of gender or pathology.
Exclusion Criteria:
- Lack of training (40 hours) in TPE for caregivers.
- ETP program not authorized or not declared to the Ile-de-France ARS.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Caregivers
Any health professional (medical or paramedical profession) practicing therapeutic education in distance mode by videoconferencing, regardless of the programs concerned
|
Individual semi-directed explication interview with phenomenological questioning centered on lived experience. The individual interview aims to collect data by questioning the participants using interview communication techniques, essentially on the "reformulation" technique. The interview is structured using an interview guide containing the list of open questions with prompts to be answered during the discussion. |
Participants
|
Individual semi-directed explication interview with phenomenological questioning centered on lived experience. The individual interview aims to collect data by questioning the participants using interview communication techniques, essentially on the "reformulation" technique. The interview is structured using an interview guide containing the list of open questions with prompts to be answered during the discussion. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Understanding of remote therapeutic education by videoconference
Time Frame: 18 months
|
Exploratory qualitative research of the lived experience of remote therapeutic education sessions by videoconference (phenomena) by interviewing participants and caregivers.
Verbatim analysis of interviews by phenomenological qualitative method : collection, organization, and interpretation of textual material derived from talk or conversation to understand the phenomena and its meaning.
The purpose of this approach is to bring out the categories of the phenomenon studied, each category representing a dimension of the phenomenon studied.
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Identify the particularities of distance therapeutic education and its success factors
Time Frame: 18 months
|
Exploratory qualitative research of the lived experience of remote therapeutic education sessions by videoconference of participants and caregivers.
Verbatim analysis of all the interviews, by the semio pragmatic phenomenology method, for identification of recurrences of theme to constitute a referencing of brakes and levers.
|
18 months
|
Develop recommendations levers for videoconferencing therapeutic education
Time Frame: 24 months
|
From the synthesis of all the data analyzed (verbatim interview analysed with semio pragmatic phenomelogy method, by answering the question : what will you advice a person who will provide remote therapeutic education ?) collect a framework of recommendations (practices from the field) to carry out a remote therapeutic education session intended for caregivers and taking into account the expectations and needs of the participants.
|
24 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Cécile Godot, MD, Assistance Publique - Hôpitaux de Paris
- Study Director: Radhia Dahmane, Assistance Publique - Hôpitaux de Paris
- Study Director: Théo TENG, Assistance Publique - Hôpitaux de Paris
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
- Chronic disease
- Therapeutic patient education
- Pediatric therapeutic education
- Videotherapeutic conferencing education
- Understanding videoconferencing therapeutic education through lived experience
- Recommendations on videoconferencing therapeutic education
- Promotion of videoconferencing therapeutic education
Additional Relevant MeSH Terms
Other Study ID Numbers
- APHP220260
- 2022-A00093-40 (Other Identifier: IDRCB Number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsRecruitingChronic Disease | Chronic Conditions, Multiple | Chronic ConditionDenmark
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsActive, not recruitingChronic Conditions, Multiple | Chronic ConditionDenmark
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
University of LimerickRecruitingChronic Conditions, MultipleIreland
-
Radboud University Medical CenterRecruitingChronic Conditions, Multiple | Chronic ConditionNetherlands
-
University of Alabama at BirminghamRecruitingDisability Physical | Chronic Conditions, Multiple | Chronic ConditionUnited States
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
Clinical Trials on Individual interview
-
Massachusetts General HospitalNational Center for Complementary and Integrative Health (NCCIH)CompletedDepression | Myocardial Infarction | Acute Coronary Syndrome | Unstable Angina | STEMI | NSTEMI - Non-ST Segment Elevation MIUnited States
-
Centre Hospitalier Universitaire de Saint EtienneGerontopole Auvergne Rhone-Alpes (AURA); Ecole des Mines de Saint-Etienne; Université...Completed
-
M.D. Anderson Cancer CenterNational Center for Complementary and Integrative Health (NCCIH)Recruiting
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Hospices Civils de LyonRecruitingBreast CancerFrance
-
Bandırma Onyedi Eylül UniversityEge UniversityRecruitingPalliative CareTurkey
-
Centre Hospitalier Universitaire de BesanconCompletedImplantable Defibrillator UserFrance
-
The University of Hong KongUnknownSmoking CessationHong Kong
-
University Hospital, CaenCompleted
-
French National Agency for Research on AIDS and...University of LyonUnknownHIV Seropositivity | AIDSFrance